{"id": "1537775800660987905", "created_at": "2022-06-17T12:34:56.000Z", "text": "Congratulations Mrs. Musk \nClick the link below to join in on all the profits \ud83e\udd11 \ud83d\udc47\nhttps://t.co/zdbY0iSaki\n$msft $Lulu $Gme $Amc $Afrm $Aapl $Bbig $cost $spy $amc $Nvda $twtr $Amd $dwac $F $M $qqq $Dltr $Wmt $Tsla $nvda $Abbv $Nflx $Googl $Khc https://t.co/YqxMQYEJwt", "author_id": "1505725882228375552"}
{"created_at": "2022-06-17T20:30:59.000Z", "text": "RT @BrandonVanZee: Here's the intro of today's #MarketOutlook video from \n@MarketScholars \n\nWatch the full video for free here:\n\nhttps://t.\u2026", "id": "1537895603551629312", "author_id": "1328694341154443266"}
{"id": "1537773669774147585", "created_at": "2022-06-17T12:26:27.000Z", "text": "$ABBV wins FDA approval for Skyrizi in Crohn\u2019s disease.", "author_id": "1363011694952394752"}
{"id": "1537789571743764481", "created_at": "2022-06-17T13:29:39.000Z", "text": "$ABBV SKYRIZI\u00ae (risankizumab-rzaa) Receives FDA Approval as the First and Only Specific Interleukin-23 (IL-23) to Treat Moderately to Severely Active Crohn's Disease in Adults https://t.co/4wvmV9KCyr", "author_id": "3142088601"}
